Crystal structure characterization of natural allantoin from edible lichen Umbilicaria esculenta

Crystals

Volumn 1, Issue 3, 2011, Pages 128-135

  Xu, Baojun ^a   Sung, Changkeun ^b   Han, Byunghee ^b  

^a BNU HKBU UNITED INTERNATIONAL COLLEGE   (China)

^b Chungnam National University   (South Korea)

Author keywords

Allantoin; Crystal; Edible lichen; Umbilicaria esculenta; X ray crystallography

Indexed keywords

EID: 84895822868     PISSN: None     EISSN: 20734352     Source Type: Journal    
DOI: 10.3390/cryst1030128     Document Type: Article

References (20)

1. Fukuoka, F.; Nakanishi, M.; Shibata, S.; Nishikawa, Y.; Takeda, T.; Tanaka, M. Polysaccharides in lichens and fungi. II. Antitumor activity on Sarcoma-180 of the polysaccharide preparations from Gyrophora esculenta, Cetraria islandica orientalis. Gann 1968, 59, 421-432.
2. Kim, C.H. Studies on the substances contained in Gyrophora esculenta lowering plasma and liver cholesterol levels Part 4. J. Iwate Med. Ass. 1982, 34, 669-672.
3. Slansky, F.J. Effect of the lichen chemicals atranorin and vulpinic acid upon feeding and growth of larvae of the yellow-striped armyworm, Spodoptera ornithogalli. Environ. Entomol. 1979, 8, 865.
4. Hirabayashi, L.; Iehata, S.; Ito, M.; Shigeta, S.; Narui, T.; Shibata, S. Inhibitory effect of a lichen polysaccharide sulfate, GE-3-S, on the replication of human immunodeficiency virus (HIV) in vitro. Chem. Pharm. Bull. 1989, 37, 2410-2412.
5. Chang, H.W.; Yoo, I.D.; Kim, J.W.; Song, K.S.; Yu, S.H. A Phospholipase A sub(2) inhibitor isolated from Umbilicaria esculenta. Kor. J. Appl. Microbiol. Biotechnol. 1995, 23, 526-530.
6. Kim, J.W.; Song, K.S.; Chang, H.W.; Yu, S.H.; Bae, K.G.; Min, T.J.; Yoo, I.D. Two phenolic compounds isolated from Umbilicaria esculenta as phospholipase A2 inhibitors. Kor. J. Mycol. 1996, 24, 237-242.
7. Anonymous. Today's drugs: allantoin. Brit. Med. J. 1967, iv, 535.
8. Fisher, A.A. Allantoin: a non-sensitizing topical medicament. Therapeutic effects of the addition of 5 percent allantoin to Vaseline. Cutis 1981, 27, 230-329.
9. Garnick, J.J.; Singh, B.; Winkley, G. Effectiveness of a medicament containing silicon dioxide, aloe, and allantoin on aphthous stomatitis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1998, 86, 550-556.
10. Pinheiro, N. Comparative effects of calcipotriol ointment (50 micrograms/g) and 5% coal tar/2% allantoin/0.5% hydrocortisone cream in treating plaque psoriasis. Br. J. Clin. Pract. 1997, 51, 16-19.
11. Smith, A., Heckelman, P., Oneil, M.J., Eds.; Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 13th ed.; Merck & Co., Inc. Merck Research Laboratories: Whitehouse Station, NJ, USA, 2001.
12. Zhang, J.T.; Zhang, Z.G.; You, K.; Fan, Y.G. Synthesis, structure and properties of 5-ureidoacetolactam. Jilin Daxue Ziran Kexue Xuebao 1992, 1, 87-89.
13. Zhang, W.L. Isolation and identification of allantoin from Hypocrella bambusae. Yunnan Daxue Xuebao, Ziran Kexueban 1994, 16, 91-92.
14. Mootz, D. The crystal structure of DL-allantoin. Acta Cryst. 1965, 19, 726-734.
15. Wang, P.; Kong, C.H.; Hu, F.; Xu, X.H. Allantoin involved in species interactions with rice and other organisms in paddy soil. Plant Soil 2007, 296, 43-51.
16. Motojima, K.; Goto, S.; Kanaya, S. Cloning and sequence analysis of cDNA for rat liver uricase. J. Biol. Chem. 1988, 263, 16677-16681.
17. Kahn, K.; Tipton, P.A. Kinetics and mechanism of allantoin racemization. Bioorg. Chem. 2000, 27, 62-72.
18. Kahn, K. Kinetic and mechanistic characterization of the urate oxidase reaction. PhD Thesis, University of Missouri, Columbia, 1998.
19. Lee, K.W.; Roush, A.H. Allantoinase assays and their application to yeast and soybean allantoinases. Arch. Biochem. Biophys. 1964, 108, 460-467.
20. Maksimovic, Z.; Malenovic, A.; Jancic, B.; Kovacevic, N. Quantification of allantoin in various Zea mays L. hybrids by RP-HPLC with UV detection. Pharmazie 2004, 59, 524-527.